Intestinal dendritic cells change in number in fulminant hepatic failure

World J Gastroenterol. 2015 Apr 28;21(16):4883-93. doi: 10.3748/wjg.v21.i16.4883.

Abstract

Aim: To investigate the change in intestinal dendritic cell (DC) number in fulminant hepatic failure (FHF).

Methods: An animal model of FHF was created. Intestinal CD11b/c was detected by immunohistochemistry and Western blot. Quantitative real-time polymerase chain reaction (PCR) was used to detect intestinal integrin-α mRNA expression. Intestinal CD83, CD86, CD74, CD3 and AKT were detected by immunohistochemistry, Western blot and PCR. Phosphorylated-AKT (p-AKT) was detected by immunohistochemistry and Western blot.

Results: In the FHF group [D-galactosamine (D-Galn) + lipopolysaccharide (LPS) group], the mice began to die after 6 h; conversely, in the D-Galn and LPS groups, the activity of mice was poor, but there were no deaths. Immunohistochemistry results showed that in FHF, the expression of CD11b/c (7988400 ± 385941 vs 1102400 ± 132273, P < 0.05), CD83 (13875000 ± 467493 vs 9257600 ± 400364, P < 0.05), CD86 (7988400 ± 385941 vs 1102400 ± 13227, P < 0.05) and CD74 (11056000 ± 431427 vs 4633400 ± 267903, P < 0.05) was significantly increased compared with the normal saline (NS) group. Compared with the NS group, the protein expression of CD11b/c (5.4817 ± 0.77 vs 1.4073 ± 0.37, P < 0.05) and CD86 (4.2673 ± 0.69 vs 1.1379 ± 0.42, P < 0.05) was significantly increased. Itg-α (1.1224 ± 0.3 vs 0.4907 ± 0.19, P < 0.05), CD83 (3.6986 ± 0.40 vs 1.0762 ± 0.22, P < 0.05) and CD86 (1.5801 ± 0.32 vs 0.8846 ± 0.10, P < 0.05) mRNA expression was increased significantly in the FHF group. At the protein level, expression of CD74 in the FHF group (2.3513 ± 0.52) was significantly increased compared with the NS group (1.1298 ± 0.33), whereas in the LPS group (2.3891 ± 0.47), the level of CD74 was the highest (P < 0.05). At the gene level, the relative expression of CD74 mRNA in the FHF group (1.5383 ± 0.26) was also significantly increased in comparison to the NS group (0.7648 ± 0.22; P < 0.05). CD3 expression was the highest in the FHF group (P < 0.05). In the FHF, LPS and D-Galn groups, the expression of AKT at the protein and mRNA levels was elevated compared with the NS group, but there was no statistical significance (P > 0.05). The p-AKT protein expression in the FHF (1.54 ± 0.06), LPS (1.56 ± 0.05) and D-Galn (1.29 ± 0.03) groups was higher than that in the NS group (1.07 ± 0.03) (P < 0.05).

Conclusion: In FHF, a large number of DCs mature, express CD86, and activate MHC class II molecular pathways to induce a T cell response, and the AKT pathway is activated.

Keywords: AKT/Phosphorylated-AKT; CD3; Fulminant hepatic failure; Intestinal dendritic cells; MHC II.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Differentiation, B-Lymphocyte / metabolism
  • B7-2 Antigen / metabolism
  • Biomarkers / metabolism
  • CD11b Antigen / metabolism
  • CD11c Antigen / metabolism
  • CD3 Complex / metabolism
  • Cell Communication
  • Cell Count
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Dendritic Cells / pathology*
  • Disease Models, Animal
  • Histocompatibility Antigens Class II / metabolism
  • Intestinal Mucosa / metabolism
  • Intestines / immunology
  • Intestines / pathology*
  • Liver Failure, Acute / immunology
  • Liver Failure, Acute / metabolism
  • Liver Failure, Acute / pathology*
  • Lymphocyte Activation
  • Mice, Inbred BALB C
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism

Substances

  • Antigens, Differentiation, B-Lymphocyte
  • B7-2 Antigen
  • Biomarkers
  • CD11b Antigen
  • CD11c Antigen
  • CD3 Complex
  • Cd86 protein, mouse
  • Histocompatibility Antigens Class II
  • invariant chain
  • Proto-Oncogene Proteins c-akt